abstract |
The present invention relates to a heterocyclic compound of the formula (I), and further discloses a pharmaceutical composition comprising the heterocyclic compound and a method for driving hematopoietic stem cells (HSC) and endothelial progenitor cells (EPC) into peripheral blood circulation using the heterocyclic compound. The present invention further provides a method of treating tissue damage, cancer, inflammatory disease, or autoimmune disease using the heterocyclic compound. |